A new professional intelligence report published by Market.us with the title “The Global Estradiol Transdermal System Market” has the ability to help the decision-makers in the most important market ...
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ...
PRINCETON, N.J. and CHARLESTON, S.C., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced a new alliance with Afaxys Pharma, LLC to ...
Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now available as a method of contraception for use in women of reproductive potential with a BMI Twirla® (levonorgestrel and ethinyl ...
Global Estradiol Transdermal System Market 2020-2029 attempts to offer significant and thoughtful insights into the current market situation and emerging growth dynamics. The report on Estradiol ...
PRINCETON, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Contraception, an ...
Noven announced that Minivelle (estradiol transdermal system) is now available. Minivelle is indicated for the treatment of moderate to severe vasomotor symptoms (eg, hot flashes, night sweats) due to ...
MIAMI, Fla. & NEW YORK -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has acquired commercialrights to Minivelle™ (estradiol ...
Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results